Journal of Aerosol Medicine and Pulmonary Drug Delivery

Papers
(The TQCC of Journal of Aerosol Medicine and Pulmonary Drug Delivery is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
The Effect of Different Interfaces on the Aerosol Delivery with Vibrating Mesh Nebulizer During Noninvasive Positive Pressure Ventilation31
Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery22
Fine Particle Fraction: The Good and the Bad21
Feasibility and Initial Safety Evaluation of Inhaled 13C-Urea in Ambulatory Patients with Pneumonia20
Pressure Drop Characteristics of the Reduced NGI Configuration with Several Common Glass Fiber Filters20
Suitability of Bronchoscopic Spraying for Fluid Deposition in Lower Airway Regions: Fluorescence Analysis on a Transparent In Vitro Airway Model17
Minimizing Aerosol Leakage from Facemasks in the COVID-19 Pandemic15
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action14
Dry Powder Inhalers: From Bench to Bedside13
An Investigation into the Factors Associated with Incorrect Use of a Pressurized Metered-Dose Inhaler in Japanese Patients12
In Vitro Effect of Combined Hypertonic Saline and Salbutamol on Ciliary Beating Frequency and Mucociliary Transport in Human Nasal Epithelial Cells of Healthy Volunteers and Patients with Cysti11
Are the Reference Values for the Provocative Concentration of Methacholine Appropriate for Children?10
Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Journal of Aerosol Medicine and Pulmonary Drug Delivery10
Pharmaceutical, Clinical, and Regulatory Challenges of Reformulating Pressurized Metered-Dose Inhalers to Reduce Their Environmental Impact9
Building on Strong Foundations: The Next Chapter in the Story of the Journal of Aerosol Medicine and Pulmonary Drug Delivery8
Optimal Inhalation Profile of Pressurized Metered Dry Powder Inhaler Using a Valved Holding Chamber: A Dynamic Analysis8
Developing Dry Powder Inhaler Formulations8
In Vitro Performance of the Wixela Inhub Inhaler Using Severe Chronic Obstructive Pulmonary Disease Patient Inhalation Profiles8
Spacers and Valved Holding Chambers8
Imaging Aerosol Deposition with Two-Dimensional Gamma Scintigraphy8
The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?7
A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis7
Nebulizers7
Heterogenous Intrapulmonary Distribution of Aerosolized Model Compounds in Mice with Bleomycin-Induced Pulmonary Fibrosis7
Multidrug Aerosol Delivery During Mechanical Ventilation6
Abstract Author Index6
Inhalation Pharmacodynamics6
Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome Subsets: Rationale and Clinical Applications6
In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler5
Practical Considerations in Dose Extrapolation from Animals to Humans5
How Cold Is Cold Enough? Refrigeration of the Next-Generation Impactor to Prevent Aerosol Undersizing5
Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease5
Safety and Efficacy of 2.5 mg and 1.25 mg Nebulized Salbutamol Compared with Placebo on Transient Tachypnea of the Newborns: A Triple-Blind Phase II/III Parallel Randomized Controlled Trial5
Inspiratory Profiles Through Easyhaler Dry Powder Inhaler During Acute Bronchoconstriction5
Acknowledgment of Reviewers 20215
Spray Drying and Particle Engineering in Dosage Form Design for Global Vaccines5
The Effects of Inspiratory Flows, Inspiratory Pause, and Suction Catheter on Aerosol Drug Delivery with Vibrating Mesh Nebulizers During Mechanical Ventilation5
Overview of Inhaled Nanopharmaceuticals5
Comparison of Vibrating Mesh and Jet Nebulizers During Noninvasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease4
Quantifying Exhaled Particles in Healthy Humans During Various Respiratory Activities Under Realistic Conditions4
Targeting Immune Cells4
Aerosol Delivery to an Adult Model via High-Flow Nasal Cannula with Inspiration-Synchronized Small-Particle Vibrating Mesh Nebulizer4
Barriers that Inhaled Particles Encounter4
The Use of Aerosolized Medications in Adult Intensive Care Unit Patients: A Prospective, Multicenter, Observational, Cohort Study4
Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles4
Acknowledgment of Reviewers 20234
Magnetic Resonance Imaging of Aerosol Deposition4
Acceptance Testing of Used Cascade Impactor Stages Based on Pressure Drop Measurements in a Flow System Managed with a Critical Flow Venturi: Part I—Laboratory Proof-of-Principle4
0.092226982116699